Standout Papers

Alteplase versus heparin ... 1993 2026 2004 2015 1993 2006 100 200 300 400 500
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation benchmark for papers published in the same subfield and year, or reaches the top citation threshold in at least one of its specific research topics.

  1. Alteplase versus heparin in acute pulmonary embolism: randomised trial assessing right-ventricular function and pulmonary perfusion
    1993 568 citations Samuel Z. Goldhaber, Patricia C. Come et al. The Lancet
  2. Procedure guideline for tumor imaging with F-18 FDG PET/CT
    2006 490 citations Dominique Delbeke, R. Edward Coleman et al.

Immediate Impact

1 by Nobel laureates 12 from Science/Nature 70 hit
Sub-graph 1 of 16

Citing Papers

Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries
2021 Hit
Mapping of human brown adipose tissue in lean and obese young men
2017 Hit
15 intermediate papers

Works of J. Anthony Parker being referenced

The SNMMI Practice Guideline for Therapy of Thyroid Disease with 131I 3.0
2012
Shareware Program for Nuclear Medicine and PET/CT PACS Display and Processing
2007
and 2 more

Author Peers

Author Last Decade Papers Cites
J. Anthony Parker 2064 1782 1356 1060 972 121 4.9k
Frederick A. Anderson 4245 1455 692 571 1929 81 6.3k
Evangelos Giannitsis 3654 1834 420 400 1321 170 5.2k
Raphael Twerenbold 4494 2228 315 566 1431 240 6.5k
Joseph Lindsay 2712 811 349 1062 1577 140 4.0k
J. Philip Kistler 1373 1187 401 2181 784 92 8.8k
Diana Bonderman 5263 780 983 4089 1128 155 8.6k
Pio Caso 6412 2221 452 886 1513 141 7.3k
Claudio Michelassi 2152 1514 218 462 730 113 4.3k
Marino Labinaz 2846 1058 346 698 1642 169 4.5k
Paul R. Eisenberg 1981 368 964 656 1034 80 4.0k

All Works

Loading papers...

Rankless by CCL
2026